Get the Weekly Intelligence Brief — top committee picks every Sunday.
HNGE · NYSE · STOCK

Hinge Health, Inc.

Healthcare Updated August 11, 2026
$89.07
52W $30.08 – $93.13
61/100
$6.89B
66.1
1.28
AI Committee Verdict
Buy
61/100
Conviction: Contested · 75% agreement · 4 analysts
Contested

Is HNGE Bullish or Bearish?

Bullish. Innellis AI committee rates Hinge Health, Inc. (HNGE) Buy with a composite score of 61/100 , based on 4 analysts with 75% agreement. Last updated August 11, 2026.

What Would Change This View

Upgrade to Strong Buy
Requires a committee score of 75.0 — +13.69 from today. Applies on the first day at or above the line; upgrades are never dampened.
Downgrade to Watch
Requires the score to fall below 55.0 — -6.31 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.

Executive Summary

The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Risk Analyst remains cautious — bollinger bandwidth of 28.9% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.

Bull & Bear Case

Bull Case
  • Price structure making higher highs and higher lows — Technical
  • MACD histogram positive -- bullish momentum — Technical
  • Trend and market structure agree -- coherent bullish picture — Technical
  • Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
  • VIX regime is low -- calm backdrop supports risk-taking — Macro
  • Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
  • Bollinger bandwidth of 28.9% signals elevated volatility — Risk
Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.
Price History (6M)

AI Investment Committee

Committee Consensus As of August 11, 2026
Overall Committee Score
61/100
Agreement
75%
Analysts
4
Conviction
Contested
Sector Rank
Top 37%
of 192 Healthcare peers
Technical Analyst bullish
69 / 100 · High confidence
Price action is constructive -- trend and momentum agree
+ Price structure making higher highs and higher lows
Risk Analyst bearish
35 / 100 · Low confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− Bollinger bandwidth of 28.9% signals elevated volatility
Macro Analyst bullish
78 / 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ VIX regime is low -- calm backdrop supports risk-taking
News Analyst bullish
64 / 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.20 across 34 articles, 14d)
Portfolio Manager neutral
55 / 100 · Moderate confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− 2 existing position pair(s) are highly correlated already
Open Full Terminal →

Technical Analysis

RSI (14)
69.6
Neutral
MACD Histogram
0.970
Bullish Momentum
Trend Direction
Uptrend
Weekly: Uptrend
Market Structure
Hh Hl
Bollinger %B
0.84
Inside Bands
Price vs Moving Averages
EMA 9
$84.16 Above
EMA 21
$81.71 Above
EMA 50
$75.73 Above
EMA 200
$58.22 Above

Fundamental Analysis

Valuation
33
Profitability
44
Financial Health
72
Cash Flow
70
Valuation
P/E Ratio 66.1×
P/B Ratio 20.37×
PEG Ratio 0.87
Dividend Yield 0.00%
52W High $93.13
52W Low $30.08
Quality & Growth
ROE -13955.4%
ROA -7093.0%
Gross Margin 8452.0%
Operating Margin 1300.9%
Revenue Growth YoY
Debt / Equity 0.02
AI Fundamental Assessment
[reduced confidence: limited earnings history] P/E ratio of 66.1 (rich relative to a 15-40x range); Price-to-book of 20.4x; PEG ratio of 0.9 (under 1.0 suggests growth is undervalued relative to price); Return on equity of -139.6%; Return on assets of -70.9%; Net margin of 15.1%; Gross margin of 84.5%; Current ratio of 1.34 (tight short-term liquidity); Debt-to-equity of 0.02; Free cash flow per share is positive (3.65); Earnings-history trend unavailable; growth based on TTM year-over-year only.
Get the Full HNGE Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →

Explore HNGE Further

📈 Rating History 💰 Earnings 📰 Recent Events 🔄 What Changed 📖 Thesis Evolution 🔍 Similar Stocks
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime